As shown by Ma et al., a significantly decreased CD4 T cell number could be seen in different mouse models for NASH-related HCC in the NAFLD stage, and CD4 T cell depletion caused more hepatic tumor lesions [63]. This evidence concerns the gene CD4 and metabolic dysfunction-associated steatotic liver disease.